Vanguard Group
RGLS

Vanguard Group’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,952,120
Closed -$6.92M 4320
2025
Q1
$6.92M Sell
3,952,120
-14,971
-0.4% -$26.2K ﹤0.01% 3043
2024
Q4
$6.27M Sell
3,967,091
-121,669
-3% -$192K ﹤0.01% 3174
2024
Q3
$6.42M Buy
4,088,760
+37,897
+0.9% +$59.5K ﹤0.01% 3166
2024
Q2
$7.23M Buy
4,050,863
+3,310,648
+447% +$5.91M ﹤0.01% 3083
2024
Q1
$2.13M Buy
740,215
+453,784
+158% +$1.31M ﹤0.01% 3571
2023
Q4
$367K Buy
286,431
+1,381
+0.5% +$1.77K ﹤0.01% 4120
2023
Q3
$391K Buy
285,050
+2,390
+0.8% +$3.27K ﹤0.01% 4125
2023
Q2
$416K Hold
282,660
﹤0.01% 4169
2023
Q1
$240K Hold
282,660
﹤0.01% 4295
2022
Q4
$387K Buy
282,660
+160
+0.1% +$219 ﹤0.01% 4168
2022
Q3
$480K Sell
282,500
-90,232
-24% -$153K ﹤0.01% 4225
2022
Q2
$772K Sell
372,732
-3,305,602
-90% -$6.85M ﹤0.01% 4169
2022
Q1
$1.1M Buy
3,678,334
+648,121
+21% +$193K ﹤0.01% 4175
2021
Q4
$955K Sell
3,030,213
-74,832
-2% -$23.6K ﹤0.01% 4278
2021
Q3
$2.15M Buy
3,105,045
+9,808
+0.3% +$6.78K ﹤0.01% 4038
2021
Q2
$2.52M Sell
3,095,237
-125,521
-4% -$102K ﹤0.01% 3903
2021
Q1
$5.03M Buy
3,220,758
+2,834,099
+733% +$4.42M ﹤0.01% 3530
2020
Q4
$522K Buy
386,659
+281,210
+267% +$380K ﹤0.01% 3945
2020
Q3
$54K Buy
105,449
+72,946
+224% +$37.4K ﹤0.01% 4063
2020
Q2
$22K Hold
32,503
﹤0.01% 4057
2020
Q1
$15K Hold
32,503
﹤0.01% 4059
2019
Q4
$29K Hold
32,503
﹤0.01% 4071
2019
Q3
$23K Hold
32,503
﹤0.01% 4125
2019
Q2
$41K Sell
32,503
-11,070
-25% -$14K ﹤0.01% 4125
2019
Q1
$44K Sell
43,573
-181,605
-81% -$183K ﹤0.01% 4068
2018
Q4
$210K Sell
225,178
-2,389,526
-91% -$2.23M ﹤0.01% 3892
2018
Q3
$517K Sell
2,614,704
-40,555
-2% -$8.02K ﹤0.01% 3846
2018
Q2
$1.75M Sell
2,655,259
-129,261
-5% -$85.2K ﹤0.01% 3540
2018
Q1
$2M Buy
2,784,520
+323,791
+13% +$232K ﹤0.01% 3461
2017
Q4
$2.56M Sell
2,460,729
-410,243
-14% -$427K ﹤0.01% 3351
2017
Q3
$3.59M Buy
2,870,972
+1,400,608
+95% +$1.75M ﹤0.01% 3232
2017
Q2
$1.45M Sell
1,470,364
-54,552
-4% -$53.8K ﹤0.01% 3479
2017
Q1
$2.52M Buy
1,524,916
+843,283
+124% +$1.39M ﹤0.01% 3310
2016
Q4
$1.53M Sell
681,633
-655,512
-49% -$1.47M ﹤0.01% 3450
2016
Q3
$4.41M Buy
1,337,145
+58,679
+5% +$194K ﹤0.01% 3069
2016
Q2
$3.69M Buy
1,278,466
+102,579
+9% +$296K ﹤0.01% 3115
2016
Q1
$8.15M Buy
1,175,887
+71,597
+6% +$496K ﹤0.01% 2719
2015
Q4
$9.63M Buy
1,104,290
+81,224
+8% +$708K ﹤0.01% 2659
2015
Q3
$6.69M Buy
1,023,066
+120,814
+13% +$790K ﹤0.01% 2830
2015
Q2
$9.89M Buy
902,252
+55,592
+7% +$609K ﹤0.01% 2680
2015
Q1
$14.3M Buy
846,660
+83,098
+11% +$1.41M ﹤0.01% 2476
2014
Q4
$12.2M Buy
763,562
+290,822
+62% +$4.66M ﹤0.01% 2455
2014
Q3
$3.23M Buy
472,740
+21,255
+5% +$145K ﹤0.01% 3062
2014
Q2
$3.63M Buy
451,485
+32,034
+8% +$258K ﹤0.01% 2997
2014
Q1
$3.78M Buy
419,451
+176,313
+73% +$1.59M ﹤0.01% 2962
2013
Q4
$1.8M Buy
243,138
+15,676
+7% +$116K ﹤0.01% 3226
2013
Q3
$2.15M Buy
227,462
+154,963
+214% +$1.46M ﹤0.01% 3103
2013
Q2
$712K Buy
+72,499
New +$712K ﹤0.01% 3396